From saralasin to sartans: history of the angiotensin II receptor blockade
The article presents the history of development of angiotensin II receptor blockers and experience of their use in controlled clinical studiesV.V. Fomin, M.M. Kurashov
Keywords
angiotensin II receptor blockers
cardiovascular complications
chronic kidney disease
controlled clinical trials



